Shira A. Mitchell, Ph.D.

2014 Biostatistics Harvard University, Cambridge, MA, United States 
Statistics, Biostatistics Biology, General Biology
"Shira Mitchell"


Sign in to add mentor
Brent Coull grad student 2014 Harvard
 (Capture-recapture Estimation for Conflict Data and Hierarchical Models for Program Impact Evaluation.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Byrne M, Leiser J, Mitchell SA, et al. (2021) Trajectories of fatigue in a population-based sample of older adult breast, prostate, and colorectal cancer survivors: an analysis using the SEER-MHOS data resource. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Karpen SR, Klein A, Alloway RR, et al. (2021) The Role of Patient-reported Outcomes and Medication Adherence Assessment in Patient-focused Drug Development for Solid Organ Transplantation. Transplantation. 105: 941-944
Pappot H, Baeksted CW, Nissen A, et al. (2021) Clinical effects of assessing electronic patient-reported outcomes monitoring symptomatic toxicities during breast cancer therapy: a nationwide and population-based study. Breast Cancer (Tokyo, Japan)
Gallicchio L, Tonorezos E, de Moor JS, et al. (2021) Evidence Gaps in Cancer Survivorship Care: A Report from the 2019 National Cancer Institute Cancer Survivorship Workshop. Journal of the National Cancer Institute
Ruben CL, Pirsl F, Steinberg SM, et al. (2021) Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host disease. Bone Marrow Transplantation
Molés-Poveda P, Comis LE, Joe GO, et al. (2020) Rehabilitation interventions in the multi-disciplinary management of patients with sclerotic graft-versus-host disease of the skin and fascia. Archives of Physical Medicine and Rehabilitation
Kkf C, Mitchell SA, Chan N, et al. (2020) Linguistic validation of the simplified Chinese version of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™). Bmc Cancer. 20: 1153
Veldhuijzen E, Walraven I, Mitchell SA, et al. (2020) Dutch translation and linguistic validation of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™). Journal of Patient-Reported Outcomes. 4: 81
de Moor JS, Gray SW, Mitchell SA, et al. (2020) Oncologist Confidence in Genomic Testing and Implications for Using Multimarker Tumor Panel Tests in Practice. Jco Precision Oncology. 4
Wolff D, Herzberg PY, Herrmann A, et al. (2020) Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease-results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health. Bone Marrow Transplantation
See more...